Evidence map›Paper›PMID 35886618›Full record

ReviewInternational journal of environmental research and public health2022

The Advantages of the Zero-COVID-19 Strategy.

Zhaohui Su, Ali Cheshmehzangi, Dean McDonnell, Junaid Ahmad, Sabina Šegalo, Yu-Tao Xiang, Claudimar Pereira da Veiga

Abstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Dynamic changes in the circulation of respiratory pathogens in children during and after the containment of the 2019 coronavirus disease pandemic in Kunming, China.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The global failure of facing the pandemic.Global health action · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhaohui SuSchool of Public Health, Southeast University, Nanjing 210009, China.ORCID 0000-0003-2005-9504
Ali CheshmehzangiFaculty of Science and Engineering, University of Nottingham Ningbo China, Ningbo 315100, China.ORCID 0000-0003-2657-4865
Dean McDonnellDepartment of Humanities, South East Technological University, R93 V960 Carlow, Ireland.
Junaid AhmadPrime Institute of Public Health, Peshawar Medical College, Warsak Road, Peshawar 25160, Pakistan.ORCID 0000-0002-8580-7529
Sabina ŠegaloFaculty of Health Studies, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina.ORCID 0000-0002-9280-3278
Yu-Tao XiangDepartment of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, Centre for Cognitive and Brain Sciences, Institute of Advanced Studies in Humanities and Social Sciences, University of Macau, Macao SAR, China.
Claudimar Pereira da VeigaFundação Dom Cabral-FDC, Av. Princesa Diana, 760 Alphaville, Lagoa dos Ingleses, Nova Lima 34018-006, MG, Brazil.ORCID 0000-0002-4960-5954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesHumansPandemicsPost-Acute COVID-19 SyndromePublic HealthCOVID-19 VaccinescoronavirusCOVID-19public health policiesvirus eliminationzero-COVID-19 strategy

Identifiers

PMID35886618
PMCPMC9317662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.